Tim Ashwood

2.7k total citations · 1 hit paper
19 papers, 2.0k citations indexed

About

Tim Ashwood is a scholar working on Epidemiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Tim Ashwood has authored 19 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Tim Ashwood's work include Acute Ischemic Stroke Management (9 papers), Stroke Rehabilitation and Recovery (3 papers) and Alzheimer's disease research and treatments (3 papers). Tim Ashwood is often cited by papers focused on Acute Ischemic Stroke Management (9 papers), Stroke Rehabilitation and Recovery (3 papers) and Alzheimer's disease research and treatments (3 papers). Tim Ashwood collaborates with scholars based in Sweden, United States and Australia. Tim Ashwood's co-authors include Patrick D. Lyden, Stephen M. Davis, Ashfaq Shuaib, Hans‐Christoph Diener, Warren W. Wasiewski, Kennedy R. Lees, James C. Grotta, Antonio Dávalos, Tomas Odergren and Hans‐Göran Hårdemark and has published in prestigious journals such as New England Journal of Medicine, Stroke and Brain Research.

In The Last Decade

Tim Ashwood

19 papers receiving 2.0k citations

Hit Papers

NXY-059 for the Treatment of Acute Ischemic Stroke 2007 2026 2013 2019 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NXY-059 for the Treatment of Acute Ischemic Stroke
    2007 523 citations Ashfaq Shuaib, Kennedy R. Lees et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Ashwood Sweden 16 947 590 505 472 244 19 2.0k
Hahn Young Kim South Korea 24 417 0.4× 620 1.1× 376 0.7× 299 0.6× 216 0.9× 76 1.8k
En Xu China 27 1.3k 1.3× 300 0.5× 469 0.9× 1.0k 2.2× 145 0.6× 66 2.6k
Joanna Pera Poland 28 419 0.4× 466 0.8× 690 1.4× 663 1.4× 355 1.5× 100 2.7k
Takao Urabe Japan 32 705 0.7× 1.2k 2.1× 1.2k 2.3× 673 1.4× 565 2.3× 138 4.0k
Alessia Lanari Italy 20 467 0.5× 269 0.5× 261 0.5× 468 1.0× 547 2.2× 34 1.7k
Matthew Schrag United States 29 668 0.7× 493 0.8× 728 1.4× 929 2.0× 930 3.8× 77 3.2k
Masao Nagayama Japan 16 299 0.3× 642 1.1× 543 1.1× 294 0.6× 394 1.6× 43 2.1k
Shawn N. Whitehead Canada 28 230 0.2× 668 1.1× 796 1.6× 203 0.4× 575 2.4× 103 2.2k
Satoshi Yuki Japan 15 272 0.3× 398 0.7× 482 1.0× 401 0.8× 320 1.3× 24 1.9k
Wei Qin China 22 211 0.2× 404 0.7× 540 1.1× 355 0.8× 540 2.2× 89 1.8k

Countries citing papers authored by Tim Ashwood

Since Specialization
Citations

This map shows the geographic impact of Tim Ashwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Ashwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Ashwood more than expected).

Fields of papers citing papers by Tim Ashwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Ashwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Ashwood. The network helps show where Tim Ashwood may publish in the future.

Co-authorship network of co-authors of Tim Ashwood

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Ashwood. A scholar is included among the top collaborators of Tim Ashwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Ashwood. Tim Ashwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hannesdóttir, Kristín, Tim Ashwood, Niclas Sjögren, et al.. (2013). P2–283: Psychometric features of the ADAS‐Cog: Identifying a potential cognition endpoint for prodromal Alzheimer's disease. Alzheimer s & Dementia. 9(4S_Part_11). 2 indexed citations
2.
Lim, Yen Ying, Robert H. Pietrzak, Kathryn A. Ellis, et al.. (2013). Rapid Decline in Episodic Memory in Healthy Older Adults with High Amyloid-β. Journal of Alzheimer s Disease. 33(3). 675–679. 56 indexed citations
3.
Huang, Yafei, Rachel Potter, Wendy Sigurdson, et al.. (2012). β-Amyloid Dynamics in Human Plasma. Archives of Neurology. 69(12). 1591–1591. 56 indexed citations
4.
Huang, Yafei, Rachel Potter, Wendy Sigurdson, et al.. (2012). β-Amyloid Dynamics in Human Plasma. JAMA Neurology. 1–1. 1 indexed citations
5.
Frölich, Lutz, et al.. (2011). Effects of AZD3480 on Cognition in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase IIb Dose-Finding Study. Journal of Alzheimer s Disease. 24(2). 363–374. 51 indexed citations
6.
Mishra, Nishant K., Ashfaq Shuaib, Patrick D. Lyden, et al.. (2011). Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy. Stroke. 42(4). 1046–1050. 34 indexed citations
7.
Diener, Hans‐Christoph, Kennedy R. Lees, Patrick D. Lyden, et al.. (2008). NXY-059 for the Treatment of Acute Stroke. Stroke. 39(6). 1751–1758. 170 indexed citations
8.
Shuaib, Ashfaq, Kennedy R. Lees, Patrick D. Lyden, et al.. (2007). NXY-059 for the Treatment of Acute Ischemic Stroke. New England Journal of Medicine. 357(6). 562–571. 523 indexed citations breakdown →
9.
Lyden, Patrick D., Ashfaq Shuaib, Kennedy R. Lees, et al.. (2007). Safety and Tolerability of NXY-059 for Acute Intracerebral Hemorrhage. Stroke. 38(8). 2262–2269. 136 indexed citations
10.
Lees, Kennedy R., Tim Ashwood, & Tomas Odergren. (2007). Response to Letter by Proctor and Tamborello. Stroke. 38(10). 1 indexed citations
11.
Ashwood, Tim, et al.. (2006). Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia. Brain Research. 1072(1). 224–226. 22 indexed citations
12.
Lees, Kennedy R., Justin A. Zivin, Tim Ashwood, et al.. (2006). NXY-059 for Acute Ischemic Stroke. New England Journal of Medicine. 354(6). 588–600. 477 indexed citations
13.
Lees, Kennedy R., Antonio Dávalos, Stephen M. Davis, et al.. (2006). Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I Trial. Stroke. 37(12). 2970–2978. 39 indexed citations
14.
15.
Lyden, Patrick D., L. Claesson, Suzanne Havstad, Tim Ashwood, & Mei Lü. (2004). Factor Analysis of the National Institutes of Health Stroke Scale in Patients With Large Strokes. Archives of Neurology. 61(11). 1677–1677. 83 indexed citations
16.
Cucchiara, Brett, Scott E. Kasner, David A. Wolk, et al.. (2004). Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Critical Care Medicine. 32(1). 241–245. 49 indexed citations
17.
Green, A. Richard, Tomas Odergren, & Tim Ashwood. (2003). Animal models of stroke: do they have value for discovering neuroprotective agents?. Trends in Pharmacological Sciences. 24(8). 402–408. 131 indexed citations
18.
Ashwood, Tim, et al.. (2003). Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059. Pharmacology & Therapeutics. 100(3). 195–214. 78 indexed citations
19.
Ekblom, Marianne, Tomas Odergren, Tim Ashwood, et al.. (2003). Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. British Journal of Clinical Pharmacology. 56(2). 173–183. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hahn Young Kim Breakdown of academic impact, for papers by En Xu Breakdown of academic impact, for papers by Joanna Pera Breakdown of academic impact, for papers by Takao Urabe Breakdown of academic impact, for papers by Alessia Lanari Breakdown of academic impact, for papers by Matthew Schrag Breakdown of academic impact, for papers by Masao Nagayama Breakdown of academic impact, for papers by Shawn N. Whitehead Breakdown of academic impact, for papers by Satoshi Yuki Breakdown of academic impact, for papers by Wei Qin
Rankless by CCL
2026